In the days since President Donald Trump signed an executive order on marijuana rescheduling this month, there’s been some misreporting that the deal is officially done. But as congressional researchers note in a new report, the reclassification must still be finalized—and there’s a chance the Justice Department could opt to start the process all over again, or even not complete it at all.
What the president did through executive action was direct the attorney general to expeditiously complete the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), in accordance with a proposed rule initiated under the Biden administration. Short of that sign-off, marijuana still remains a Schedule I drug.
“At the time the executive order was issued, the agencies had not taken final action on the proposed rescheduling, and it remains to be seen whether and when they will do so,” the Congressional Research Service (CRS) said in an analysis published last week. “It remains to be seen whether DOJ will take final action to reschedule marijuana and, if so, when and how the agency will act.”
So far, the Justice Department has been silent on potential next steps. Attorney General Pam
Read full article on Marijuana Moment
